Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
James McKay(Centre international de recherche sur le cancer), Lynne R. Wilkens(University of Hawaiʻi at Mānoa), Pier Alberto Bertazzi(University of Milan), Adonina Tardón(Universidad de Oviedo), Stephen Lam(University of British Columbia), Jinyoung Byun(Dartmouth College), Younghun Han(University of New Mexico), Angeline S. Andrew(Dartmouth College), Melinda C. Aldrich(Vanderbilt University Medical Center), Natasha B. Leighl(Princess Margaret Cancer Centre), Xuchen Zong(Mount Sinai Hospital), Nancy Diao(Harvard University), Neil E. Caporaso(Unknown), Yonathan Brhane(University of Toronto), Ruyang Zhang(Hunan Agricultural University), Demetrius Albanes(National Cancer Institute), Karen A. Pooley(University of Cambridge), Mattias Johansson(Centre international de recherche sur le cancer), John K. Field(University of Liverpool), Alison M. Dunning(University of Cambridge), M. Dawn Teare(University of Sheffield), Aage Haugen, Lambertus A. Kiemeney(Radboud University Nijmegen), Xiangjun Xiao(Dartmouth College), Anders Mellemgaard(AstraZeneca (United Kingdom)), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Christopher A. Haiman(University of Southern California), William S. Bush(Case Western Reserve University), Matthew B. Schabath(Moffitt Cancer Center), Xifeng Wu(Zhejiang Lab), Xuemei Ji(The Ohio State University), Heike Bickeböller(Nephrologisches Zentrum Goettingen), Yun‐Chul Hong(National University College), Stig E. Bojesen(University of Copenhagen), Walid Saliba(Technion – Israel Institute of Technology), Robert Carreras‐Torres(Institut de Biologia Evolutiva), David C. Qian(Dartmouth College), Philip Lazarus(University at Buffalo, State University of New York), Yuanqing Ye(The University of Texas MD Anderson Cancer Center), Gad Rennert(Technion – Israel Institute of Technology), Maria Timofeeva(Institute of Genetics and Cancer), David C. Christiani(Harvard University), Li Su(Harvard University), Geoffrey Liu(Princess Margaret Cancer Centre), Yafang Li(Sichuan Agricultural University), Jian‐Min Yuan(University of Pittsburgh), Hongbing Shen(Jiangsu Cancer Hospital), Jakob Sidenius Johansen(Gentofte Hospital), Angela Cecilia Pesatori(University of Milan)
Cited by 804
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|3.2k
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures
|Biostatistics|2014|1.8k